Understanding the Role of MyCareGorithm as a Visual Digital Platforms in Cancer Treatment Education and Patient Comprehension of Oncology Treatment Plans
The purpose of this research study is to learn if a digital communication tool can improve how well patients with head and neck cancer and their caregivers understand the disease and treatment plan after their first consultation visit with the doctor/nurse practitioner.
연구 개요
상세 설명
Primary Objective:
The primary objective of this pilot study is to determine whether use of a novel digital visual communication tool improves patient understanding and satisfaction with their initial multidisciplinary consultation for head and neck and prostate cancer. Specifically, the study seeks to answer the scientific question:
• Do at least 75% of newly diagnosed head and neck and prostate cancer patients report being "satisfied" (≥4 positive responses on a 6-item survey) after use of the digital communication tool, and is this proportion significantly greater than 50%?
Secondary Objectives:
Caregiver Understanding and Satisfaction
• What proportion of caregivers of newly diagnosed patients report satisfaction with their understanding of the patient's disease and treatment after using the tool, and how confident can we be in this estimate (95% Clopper-Pearson CI)?
Provider Experience and Communication Effectiveness
• What proportion of providers report satisfaction (≥5 positive responses on a 7-item survey) with the tool's ability to improve communication efficiency and consultation quality for patients they treated?
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Steven J Frank, MD
- 전화번호: (713) 563-3601
- 이메일: sjfrank@mdanderson.org
연구 장소
-
-
Texas
-
Houston, Texas, 미국, 77030
- UT MD Anderson
-
연락하다:
- Steven J Frank, MD
- 전화번호: 713-563-3601
- 이메일: sjfrank@mdanderson.org
-
수석 연구원:
- Steven Frank, MD
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
Patients
- Adults aged 18 to 100 years.
- Diagnosed with head and neck cancer (all histologies included).
- Receiving treatment for head and neck and prostate cancer at MDACC
- Able to speak and understand English
Caregivers
- Adults (≥18 years old).
- Identified as a caregiver to a patient who meets the above patient inclusion criteria.
- Able to speak and understand English.
Providers
- Doctors or nurse practitioners practicing in the field of radiation oncology and actively participating in initial consultations for patients with head and neck cancer and prostate cancer.
- Must complete the provider survey after the consultation.
Exclusion Criteria:
Patients
- Individuals without a diagnosis of head and neck cancer or prostate cancer.
- Patients who do not speak English (since the digital tool is not translated).
Caregivers
- Adults who are not caregivers of the eligible patient
- Caregivers who do not speak English (tool not translated).
Providers
- Doctors or nurse practitioners not practicing in the field of radiation oncology and not part of the initial consultation process.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 장치 타당성
- 할당: 해당 없음
- 중재 모델: 단일 그룹 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Patient/Caregiver: Use of MyCareGorithm
Following use of the digital visual communication tool by the provider, patients and any accompanying caregivers will be asked to complete their surveys via REDCap. Providers will complete their survey immediately after the consultation with each participating patient, also via REDCap. Each survey requires approximately 5 minutes to complete. No follow-up surveys or repeat administrations are planned. |
A 6-item structured questionnaire with Yes/No response options, followed by one open-ended free-text question. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Safety and Adverse Events (AEs)
기간: Through study completion; an average of 1 year
|
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0 |
Through study completion; an average of 1 year
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Steven J Frank, MD, UT MD Anderson
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- 2026-1108
- NCI-2026-07264 (기타 식별자: NCI-CTRP Clinical Trials Registry)
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .